Invited review: Selective treatment of clinical mastitis in dairy cattle
Research output: Contribution to journal › Review › Research › peer-review
Standard
Invited review : Selective treatment of clinical mastitis in dairy cattle. / de Jong, Ellen; McCubbin, Kayley D.; Speksnijder, David; Dufour, Simon; Middleton, John R.; Ruegg, Pamela L.; Lam, Theo J.G.M.; Kelton, David F.; McDougall, Scott; Godden, Sandra M.; Lago, Alfonso; Rajala-Schultz, Päivi J.; Orsel, Karin; De Vliegher, Sarne; Krömker, Volker; Nobrega, Diego B.; Kastelic, John P.; Barkema, Herman W.
In: Journal of Dairy Science, Vol. 106, No. 6, 2023, p. 3761-3778.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Invited review
T2 - Selective treatment of clinical mastitis in dairy cattle
AU - de Jong, Ellen
AU - McCubbin, Kayley D.
AU - Speksnijder, David
AU - Dufour, Simon
AU - Middleton, John R.
AU - Ruegg, Pamela L.
AU - Lam, Theo J.G.M.
AU - Kelton, David F.
AU - McDougall, Scott
AU - Godden, Sandra M.
AU - Lago, Alfonso
AU - Rajala-Schultz, Päivi J.
AU - Orsel, Karin
AU - De Vliegher, Sarne
AU - Krömker, Volker
AU - Nobrega, Diego B.
AU - Kastelic, John P.
AU - Barkema, Herman W.
N1 - Funding Information: This study was funded by the Canada's Natural Sciences and Engineering Research Council (NSERC) Industrial Research Chair Program granted to Herman Barkema, with industry contributions from Alberta Milk (Edmonton, AB, Canada), Dairy Farmers of Canada (Ottawa, ON, Canada), Dairy Farmers of Manitoba (Winnipeg, MB, Canada), British Columbia Dairy Association (Burnaby, BC, Canada), WestGen Endowment Fund (Abbotsford, BC, Canada), Lactanet (Guelph, ON, Canada), SaskMilk (Regina, SK, Canada), and MSD Animal Health (Boxmeer, the Netherlands). Ellen de Jong was supported by an NSERC CREATE in Milk Quality Program Scholarship. Data collection forms, analytic code, and any other materials used in the review are available from the corresponding author upon reasonable request. No human or animal subjects were used, so this analysis did not require approval by an Institutional Animal Care and Use Committee or Institutional Review Board. The authors have not stated any conflicts of interest. Publisher Copyright: © 2023 American Dairy Science Association
PY - 2023
Y1 - 2023
N2 - Treatment of clinical mastitis (CM) and use of antimicrobials for dry cow therapy are responsible for the majority of animal-defined daily doses of antimicrobial use (AMU) on dairy farms. However, advancements made in the last decade have enabled excluding nonsevere CM cases from antimicrobial treatment that have a high probability of cure without antimicrobials (no bacterial causes or gram-negative, excluding Klebsiella spp.) and cases with a low bacteriological cure rate (chronic cases). These advancements include availability of rapid diagnostic tests and improved udder health management practices, which reduced the incidence and infection pressure of contagious CM pathogens. This review informed an evidence-based protocol for selective CM treatment decisions based on a combination of rapid diagnostic test results, review of somatic cell count and CM records, and elucidated consequences in terms of udder health, AMU, and farm economics. Relatively fast identification of the causative agent is the most important factor in selective CM treatment protocols. Many reported studies did not indicate detrimental udder health consequences (e.g., reduced clinical or bacteriological cures, increased somatic cell count, increased culling rate, or increased recurrence of CM later in lactation) after initiating selective CM treatment protocols using on-farm testing. The magnitude of AMU reduction following a selective CM treatment protocol implementation depended on the causal pathogen distribution and protocol characteristics. Uptake of selective treatment of nonsevere CM cases differs across regions and is dependent on management systems and adoption of udder health programs. No economic losses or animal welfare issues are expected when adopting a selective versus blanket CM treatment protocol. Therefore, selective CM treatment of nonsevere cases can be a practical tool to aid AMU reduction on dairy farms.
AB - Treatment of clinical mastitis (CM) and use of antimicrobials for dry cow therapy are responsible for the majority of animal-defined daily doses of antimicrobial use (AMU) on dairy farms. However, advancements made in the last decade have enabled excluding nonsevere CM cases from antimicrobial treatment that have a high probability of cure without antimicrobials (no bacterial causes or gram-negative, excluding Klebsiella spp.) and cases with a low bacteriological cure rate (chronic cases). These advancements include availability of rapid diagnostic tests and improved udder health management practices, which reduced the incidence and infection pressure of contagious CM pathogens. This review informed an evidence-based protocol for selective CM treatment decisions based on a combination of rapid diagnostic test results, review of somatic cell count and CM records, and elucidated consequences in terms of udder health, AMU, and farm economics. Relatively fast identification of the causative agent is the most important factor in selective CM treatment protocols. Many reported studies did not indicate detrimental udder health consequences (e.g., reduced clinical or bacteriological cures, increased somatic cell count, increased culling rate, or increased recurrence of CM later in lactation) after initiating selective CM treatment protocols using on-farm testing. The magnitude of AMU reduction following a selective CM treatment protocol implementation depended on the causal pathogen distribution and protocol characteristics. Uptake of selective treatment of nonsevere CM cases differs across regions and is dependent on management systems and adoption of udder health programs. No economic losses or animal welfare issues are expected when adopting a selective versus blanket CM treatment protocol. Therefore, selective CM treatment of nonsevere cases can be a practical tool to aid AMU reduction on dairy farms.
KW - antimicrobial use
KW - clinical mastitis
KW - dairy cattle
KW - rapid diagnostic tests
KW - selective treatment
U2 - 10.3168/jds.2022-22826
DO - 10.3168/jds.2022-22826
M3 - Review
C2 - 37080782
AN - SCOPUS:85152912268
VL - 106
SP - 3761
EP - 3778
JO - Journal of Dairy Science
JF - Journal of Dairy Science
SN - 0022-0302
IS - 6
ER -
ID: 345275757